In vitro, its silencing inhibited cancer cell migration and invasion and reduced phospho-Smad2 and phospho-Smad4 levels, while its ectopic expression promoted gastric cancer progression and counteracted TGF-β inhibitors. The gene discussed is TGFB1; the disease is cancer.